Advances in Osteoporosis Therapy: Focus on Osteoanabolic Agents, Secondary Fracture Prevention, and Perioperative Bone Health

PURPOSE OF REVIEW: This review summarizes recently published data and other developments around osteoanabolic osteoporosis therapies in patients with very high fracture risk, including those undergoing bone-related surgery. RECENT FINDINGS: Two osteoanabolic agents, abaloparatide and romosozumab, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostenuik, Paul J., Binkley, Neil, Anderson, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393898/
https://www.ncbi.nlm.nih.gov/pubmed/37289382
http://dx.doi.org/10.1007/s11914-023-00793-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393898/
https://www.ncbi.nlm.nih.gov/pubmed/37289382
http://dx.doi.org/10.1007/s11914-023-00793-8

Ejemplares similares